CBMG
Cellular Biomedicine Group, Inc.
CBMG
CBMG
Delisted
CBMG was delisted on the 19th of February, 2021.
35 hedge funds and large institutions have $14.7M invested in Cellular Biomedicine Group, Inc. in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
4
Closed
1
Calls
$221K
Puts
–
Net Calls
+$221K
Net Calls Change
+$221K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $23K | +$5.82K | +493 | +34% |
|
27
BlackRock
New York
| $19K | +$11.7K | +959 | +159% |
|
28
Citigroup
New York
| $15K | -$84.4K | -6,866 | -85% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $10K | +$9.65K | +838 | +2,793% |
|
30
BNP Paribas Financial Markets
Paris,
France
| $8.07K | +$7.11K | +593 | +741% |
|
31
Creative Planning
Overland Park,
Kansas
| $4K | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $4K | +$4K | +329 | New |
|
33
Morgan Stanley
New York
| $1K | -$920 | -46 | -48% |
|
|
MFS
34
MSI Financial Services
Springfield,
Massachusetts
| $1K | – | – | – |
|
|
MLICM
35
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$161K | -8,651 | Closed |
|